+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cells - Global Strategic Business Report

  • PDF Icon

    Report

  • 369 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1206769
The global market for Stem Cells is estimated at US$12.9 Billion in 2023 and is projected to reach US$21.3 Billion by 2030, growing at a CAGR of 7.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the stem cells market is driven by several factors. Technological advancements, such as the development of CRISPR-Cas9 and other gene-editing tools, have enhanced the precision and efficacy of stem cell therapies, making them more viable for clinical use. These advancements have enabled researchers to develop targeted therapies that can address the root causes of diseases at the genetic level. The increasing prevalence of chronic diseases and degenerative conditions has expanded the addressable market for stem cell treatments, as these therapies offer hope for conditions that currently lack effective treatments. Diseases such as Alzheimer`s, multiple sclerosis, and osteoarthritis are areas where stem cell research is actively being pursued. Consumer behavior trends, including rising awareness and acceptance of regenerative medicine, have also propelled market growth. Patients and healthcare providers are increasingly recognizing the potential of stem cell therapies to provide innovative treatments for previously untreatable conditions. Additionally, substantial funding from government and private sectors, along with favorable regulatory frameworks, has accelerated research and development activities in the field. The expansion of stem cell banking services and the growing trend of personalized medicine have further fueled demand for stem cell-based therapies. Overall, the convergence of scientific innovation, increasing healthcare needs, and supportive regulatory and financial environments is driving robust growth in the stem cell market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Adult Stem Cells segment, which is expected to reach US$17.8 Billion by 2030 with a CAGR of a 7.2%. The Other Product Types segment is also set to grow at 8.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $3.5 Billion in 2023, and China, forecasted to grow at an impressive 6.8% CAGR to reach $3.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Stem Cells Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stem Cells Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Stem Cells Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as apceth Biopharma GmbH, Athersys Inc., AVIVA BioSciences Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 233 Featured):

  • apceth Biopharma GmbH
  • Athersys Inc.
  • AVIVA BioSciences Corporation
  • BioE Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics Inc.
  • Cryo-Cell International Inc.
  • Cytori Therapeutics Inc.
  • ESI BIO
  • Gamida Cell Ltd.
  • Holostem Terapie Avanzate
  • International Stem Cell Corp.
  • Kangstem Biotech. Ltd.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Neuralstem Inc.
  • Nuvasive Inc.
  • OncoMed Pharmaceuticals Inc.
  • Osiris Therapeutics Inc.
  • Promethera Biosciences S.A.N.V
  • Reliance Life Sciences
  • ReNeuron Group Plc.
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takara Bio USA Inc.
  • TiGenix NV
  • U.S Stem Cell Inc.
  • ViaCord

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Stem Cells - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Technological Advancements in CRISPR-Cas9 Gene Editing Propel Growth
  • Rise of 3D Bioprinting Expands Addressable Market Opportunity
  • Increasing Prevalence of Chronic and Degenerative Diseases Drives Demand
  • Establishment of Stem Cell Banks Generates Long-Term Market Opportunities
  • Advancements in Stem Cell Culture and Differentiation Techniques Accelerate Market Growth
  • Expansion of Clinical Trials for Diverse Therapeutic Applications Drives Adoption
  • Consumer Awareness and Acceptance of Regenerative Medicine Impacts Market Dynamics
  • Integration of AI and Machine Learning in Stem Cell Research Enhances Precision and Efficacy
  • Ethical and Legal Considerations Create Challenges and Opportunities
  • Impact of Global Health Trends on Stem Cell Therapy Adoption
  • Development of Novel Delivery Systems for Stem Cell Therapies Generates Demand
  • Innovations in Disease Modeling and Drug Testing Using Stem Cells Drive Market Dynamics
  • Growing Demand for Tissue Engineering and Regenerative Medicine Applications Expands Market Scope
  • Influence of Biobanks and Biorepositories on Research and Therapeutic Access
  • Emergence of New Stem Cell Sources and Types Impact the Market
  • Advancements in Immunotherapy and Cancer Treatments Using Stem Cells Propel Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Stem Cells Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 12: USA Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 13: USA 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 14: USA Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 15: USA 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
CANADA
  • Table 16: Canada Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 17: Canada 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 18: Canada Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 19: Canada 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
JAPAN
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: Japan 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 22: Japan Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 23: Japan 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
CHINA
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 24: China Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 25: China 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 26: China Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: China 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
EUROPE
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 28: Europe Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 29: Europe 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 30: Europe Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
FRANCE
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 34: France Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: France 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 36: France Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: France 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
GERMANY
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 38: Germany Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Germany 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 40: Germany Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: Germany 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
ITALY
  • Table 42: Italy Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 43: Italy 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 44: Italy Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Italy 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
UNITED KINGDOM
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 46: UK Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: UK 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 48: UK Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: UK 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Rest of Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 52: Rest of Europe Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: Rest of Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
ASIA-PACIFIC
  • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 54: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: Asia-Pacific 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Asia-Pacific 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
REST OF WORLD
  • Table 58: Rest of World Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: Rest of World 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
  • Table 60: Rest of World Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: Rest of World 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • apceth Biopharma GmbH
  • Athersys Inc.
  • AVIVA BioSciences Corporation
  • BioE Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics Inc.
  • Cryo-Cell International Inc.
  • Cytori Therapeutics Inc.
  • ESI BIO
  • Gamida Cell Ltd.
  • Holostem Terapie Avanzate
  • International Stem Cell Corp.
  • Kangstem Biotech. Ltd.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Neuralstem Inc.
  • Nuvasive Inc.
  • OncoMed Pharmaceuticals Inc.
  • Osiris Therapeutics Inc.
  • Promethera Biosciences S.A.N.V
  • Reliance Life Sciences
  • ReNeuron Group Plc.
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takara Bio USA Inc.
  • TiGenix NV
  • U.S Stem Cell Inc.
  • ViaCord

Table Information